Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of chemotherapy"
DOI: 10.1080/1120009x.2022.2104295
Abstract: The goal of the research was to investigate if a combination of vincristine, irinotecan and temozolomide (VIT) could benefit adult patients with metastatic Ewing sarcoma who had already been heavily pretreated. Metastatic Ewing sarcoma patients… read more here.
Keywords: ewing sarcoma; efficacy vit; irinotecan temozolomide; metastatic ewing ... See more keywords
Role of Metastatic Site Irradiation in Pediatric Patients With Metastatic Ewing Sarcoma
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000001752
Abstract: Background: The use of radiation therapy to treat metastases in patients with metastatic Ewing sarcoma (MES) has been controversial and variable. The authors report outcomes and patterns of failure after metastatic site irradiation (MSI). Procedure:… read more here.
Keywords: msi; site; versus; metastatic ewing ... See more keywords
First-line Anti-GD2 Therapy Combined With Consolidation Chemotherapy in 3 Patients With Newly Diagnosed Metastatic Ewing Sarcoma or Ewing-like Sarcoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000002488
Abstract: Despite multimodal therapy, the prognosis of patients with metastatic Ewing sarcoma (ES) remains poor, with new treatments urgently needed. The disialoganglioside GD2, a well-established tumor-associated antigen, is expressed in 40% to 90% of ES cells,… read more here.
Keywords: sarcoma; gd2; like sarcoma; metastatic ewing ... See more keywords
Socioeconomic disparities in survival outcomes among children with non-metastatic Ewing sarcoma treated on upfront Children’s Oncology Group clinical trials.
Sign Up to like & getrecommendations! Published in 2025 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2025.43.16_suppl.10041
Abstract: 10041 Background: Poverty is emerging as an adverse risk factor for relapse and death across many pediatric cancers. Socioeconomic disparities have not been comprehensively investigated in Ewing sarcoma. We leveraged Children’s Oncology Group (COG) data… read more here.
Keywords: oncology; non metastatic; poverty; ewing sarcoma ... See more keywords